Skip to content
Veracy Advisory Platform
← All prompts

Accelerated Approval & Breakthrough Designation Strategy

Executive Executive Life Sciences

The prompt

$18

Why this works

Breakthrough designation accelerates development and regulatory review, bringing therapies to patients faster.

Risks & review

Breakthrough designation requires FDA discretion and competitive advantage proof. Post-approval confirmatory trials are mandatory; failures require label restrictions or withdrawal.